Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for α1-adrenoceptor antagonists
- 28 February 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 10 (2) , 361-369
- https://doi.org/10.1016/s0968-0896(01)00286-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Design, synthesis and biological evaluation of pyridine-phenylpiperazines: A novel series of potent and selective α1a-adrenergic receptor antagonistBioorganic & Medicinal Chemistry, 2000
- Comparative molecular field analysis of some pyridazinone-containing α1-AntagonistsBioorganic & Medicinal Chemistry, 1999
- WB 4101-Related Compounds. 2. Role of the Ethylene Chain Separating Amine and Phenoxy Units on the Affinity for α1-Adrenoreceptor Subtypes and 5-HT1A ReceptorsJournal of Medicinal Chemistry, 1999
- Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 6. Role of the Dioxane Unit on Selectivity for α1-Adrenoreceptor SubtypesJournal of Medicinal Chemistry, 1999
- Molecular cloning, genomic characterization and expression of novel human α1A‐adrenoceptor isoformsFEBS Letters, 1998
- Analysis of Conformational Coverage. 1. Validation and Estimation of CoverageJournal of Chemical Information and Computer Sciences, 1995
- Analysis of Conformational Coverage. 2. Applications of Conformational ModelsJournal of Chemical Information and Computer Sciences, 1995
- Pyrimido[5,4-b]indole derivatives. 1. A new class of potent and selective .alpha.1 adrenoceptor ligandsJournal of Medicinal Chemistry, 1991
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973